文献速递心律失常

远程监测反馈可提升房颤患者NOAC服药依从性

Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation.
PubMed 文献 · Eur Heart J · 2018-01-01

该随机、单盲、交叉对照试验纳入48例服用每日一次或两次NOAC的房颤患者,比较每日远程监测、监测加即时电话反馈及无每日传输观察三阶段各3个月的依从性。远程监测即可使服药依从性和方案依从性达97.4%和93.8%,加反馈后升至99.0%和96.8%;停监测后依从性回落至94.3%。

要点

  • 远程监测本身即可使NOAC服药依从性达97.4%、方案依从性达93.8%。
  • 对服药错误即时电话反馈可将服药与方案依从性进一步提升至99.0%和96.8%。
  • 停用每日监测后依从性显著回落,提示「被关注」效应是依从性改善的重要机制。

核心结论

  • 远程监测因患者感到被关注而带来高NOAC依从性,反馈可进一步优化依从性。
  • 对判定依从性差的高危患者,带或不带反馈的远程监测可能是具成本效益的策略。

研究设计与样本

  • 随机、单盲、交叉、对照试验,纳入48例服用每日一次或每日两次NOAC的房颤患者。
  • 用药物事件监测系统追踪NOAC摄入,分每日远程监测、监测加即时电话反馈、无每日传输观察三阶段,每阶段3个月。
  • 未保护日定义为BID或OD NOAC分别连续漏服≥3次或≥1次,或过量摄入。

主要发现

  • 全程坚持率为98%。
  • 仅远程监测阶段服药依从性97.4%、方案依从性93.8%。
  • 直接反馈使服药依从性升至99.0%(P < 0.001)、方案依从性升至96.8%(P = 0.002)。
  • 无每日监测观察阶段服药依从性显著回落至94.3%(P = 0.049)。
  • OD较BID的NOAC服药依从性显著更高,但未保护日相似。

关键数值与推荐

  • 未保护日阈值:BID连续漏服≥3次或OD连续漏服≥1次,或过量摄入。
  • 反馈干预每预防一例卒中增量成本为€344 289,高危且低依从并优化技术时可低至€15 488。

临床怎么用

  • 对服用NOAC的房颤患者可采用远程监测提升依从性,并对摄入错误给予即时电话反馈。
  • 对依从性差的高危患者,远程监测(含或不含反馈)可作为具成本效益的依从性管理手段。
  • 即使监测期间依从性很高,停止每日监测后仍应警惕依从性回落。

局限性

  • 样本量仅48例,为单中心交叉设计。
  • 成本效益基于依从性推算的预期卒中下降,非直接观察的卒中结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: To evaluate the effect of telemonitoring on adherence to non-vitamin K antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients. METHODS AND RESULTS: A randomized, single-blind, crossover, controlled trial in 48 AF patients on once or twice daily (OD or BID) NOAC. The Medication Event Monitoring System tracked NOAC intake during three phases of 3 months each: daily telemonitoring, telemonitoring with immediate telephone feedback in case of intake errors, and an observation phase without daily transmissions. Unprotected days were defined as ≥ 3 or ≥ 1 consecutively missed doses for a BID or OD NOAC, respectively, or excess dose intake. Cost-effectiveness was calculated based on anticipated stroke reduction derived from patients' risk profile and measured intake. Persistence over the entire study was 98%. Telemonitoring-only already led to very high taking and regimen adherence (97.4% respectively 93.8%). Nevertheless, direct feedback further improved both to 99.0% and 96.8%, respectively (P < 0.001 respectively P = 0.002). Observation without daily monitoring resulted in a significant waning of taking adherence (94.3%; P = 0.049). Taking adherence was significantly higher for OD compared to BID NOAC, although unprotected days were similar. Feedback intervention had an incremental cost of €344 289 to prevent one stroke, but this could be as low as €15 488 in high-risk patients with low adherence and optimized technology. CONCLUSION: Telemonitoring resulted in high NOAC adherence due to the notion of being watched, as evidenced by the rapid decline during the observation period. Feedback further optimized adherence. Telemonitoring with or without feedback may be a cost-effective approach in high-risk patients deemed poorly adherent.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Desteghe L, Vijgen J, Koopman P, et al. Telemonitoring-based feedback improves adherence to non-vitamin K antagonist oral anticoagulants intake in patients with atrial fibrillation. Eur Heart J. 2018. PMID: 29300888. doi:10.1093/eurheartj/ehx762

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。